Home › Funds › CaixaBank, S.A. › EW
CaixaBank, S.A. position in EW
EDWARDS LIFESCIENCES · Health Care
CaixaBank, S.A. reported holding 1,170,938 shares of EW (EDWARDS LIFESCIENCES) in its Q3 2026 13F filing — a position valued at US$101.1M, representing 0.45% of its reported portfolio and ranking #50 among its reported holdings. CaixaBank, S.A. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
How CaixaBank, S.A.'s EW position evolved
CaixaBank, S.A. first disclosed a stake in EW in Q3 2023 at 458,431 shares (US$31.8M). The position peaked in Q4 2025 at 1,432,302 shares, worth US$122.1M. Across 13 filings, CaixaBank, S.A. increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,170,938 shares valued at US$101.1M — an increase of 229,461 shares quarter over quarter.. Notable position changes include a 135% increase in Q4 2024 (shares fell 2% over the following quarter), a 38% increase in Q1 2025 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 458.43K | $31.76M | New |
| Q4 2023 | 436.21K | $33.26M | Reduce |
| Q1 2024 | 374.44K | $35.79M | Reduce |
| Q2 2024 | 426.62K | $39.41M | Add |
| Q3 2024 | 342.74K | $22.62M | Reduce |
| Q4 2024 | 804.77K | $59.58M | Add |
| Q1 2025 | 1.11M | $80.47M | Add |
| Q2 2025 | 1.34M | $105.18M | Add |
| Q3 2025 | 1.36M | $105.43M | Add |
| Q4 2025 | 1.43M | $122.10M | Add |
| Q1 2026 | 1.12M | $90.03M | Reduce |
| Q2 2026 | 941.48K | $85.17M | Reduce |
| Q3 2026 | 1.17M | $101.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES) is a Health Care company. 28 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), Ninety One UK Ltd (US$1.03B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$923.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- Belvedere Trading LLC 3.30M sh · $25.63B · Q3 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 10.70M sh · $923.71M · Q3 2026
- Arrowstreet Capital 10.19M sh · $879.93M · Q3 2026
- Aristotle Capital Management, LLC 8.12M sh · $700.72M · Q3 2026
- BROWN ADVISORY INC 6.46M sh · $557.32M · Q3 2026
- Artisan Partners Limited Partnership 6.09M sh · $525.69M · Q3 2026
More on CaixaBank, S.A.
FAQ
How long has CaixaBank, S.A. held EW?
CaixaBank, S.A. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CaixaBank, S.A.'s current position in EW?
As of Q3 2026, CaixaBank, S.A. holds 1.17M shares of EW (EDWARDS LIFESCIENCES), valued at $101.08M, representing 0.45% of its reported portfolio and ranking #50.
Has CaixaBank, S.A. been buying or selling EW?
In the latest 13F filing (Q3 2026), CaixaBank, S.A. increased its position in EW. The position peaked in Q4 2025 at 1.43M shares.
Which other funds hold EW?
Other major institutional holders of EW include Belvedere Trading LLC, Ninety One UK Ltd, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.